Healthcare / Medical DistributionTokyo
$1189.00
-16.00 (-1.33%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 15%
FCF escenarios
weak_data · normalized FCF $1.6B · quality 32.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$32.7B
P/E
15.6x
↓EV/EBITDA
5.8x
↓ROE
8.4%
↑Gross Margin
12.2%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+7.0%
FCF CAGR
—
FCF margin
2.0%
FCF / Net income
0.79x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $81.41B · net income $2.02B · FCF $1.59B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $81.41B | $81.41B | $77.06B | $70.85B | $66.39B |
| Net Income | $2.02B | $2.02B | $1.84B | $2.05B | $1.83B |
| EBITDA | $3.10B | $3.10B | $2.92B | $3.11B | $2.82B |
| EPS | 70.45 | 70.45 | 64.40 | 72.04 | 63.88 |
| Gross Margin | 12.2% | 12.2% | 12.4% | 12.2% | 12.8% |
| Operating Margin | 3.4% | 3.4% | 3.4% | 3.5% | 4.2% |
| Net Margin | 2.5% | 2.5% | 2.4% | 2.9% | 2.8% |
| Balance Sheet | |||||
| Current Ratio | 1.70 | 1.70 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.59B | $1.59B | $2.54B | $-525.2M | $-136.9M |
| Returns | |||||
| ROE | 8.4% | 8.4% | 7.9% | 9.0% | 8.4% |
| Valuation | |||||
| P/E | 15.64 | 15.64 | 18.45 | 14.02 | 15.70 |
| EV/EBITDA | 5.77 | 5.77 | 5.39 | 3.84 | 4.68 |
| P/B | 1.42 | 1.42 | 1.45 | 1.26 | 1.32 |
| Growth & Yield | |||||
| Revenue Growth | 5.6% | 5.6% | 8.8% | 6.7% | — |
| EPS Growth | 9.4% | 9.4% | -10.6% | 12.8% | — |
| Dividend Yield | 9.1% | 9.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
14.4%
EPS terminal req.
$105.50
Spread vs growth
-5.0%
5Y implied EPS CAGR
12.6%
EPS terminal req.
$127.66
Spread vs growth
-3.2%
10Y implied EPS CAGR
11.3%
EPS terminal req.
$205.60
Spread vs growth
-1.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.3%
Start / end P/E
19.8x → 16.9x
EPS bridge
64.40 → 70.45
Residual
-1.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.